Lv11
30 积分 2023-08-20 加入
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY
23分钟前
待确认
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
14天前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
20天前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
27天前
已完结
Small-cell lung cancer: what we know, what we need to know and the path forward
27天前
已完结
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study
1个月前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
1个月前
已完结
The prognostic role of Geriatric 8 in patients with cancer: a meta-analysis and systematic review
1个月前
已完结
SMARCA4: Promises and challenges in the treatment of Cancers
1个月前
已完结
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer
1个月前
已完结
皖公网安备34019202002308
